Reduced susceptibility to two-stage skin carcinogenesis in mice with epidermis-specific deletion of CD151

Norman Sachs1, Pablo Secades1, Laura van Hulst1

  • 1Division of Cell Biology, The Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.

Insights

Tetraspanin CD151 plays a critical role in skin carcinogenesis. Mice lacking CD151 in their epidermis showed reduced tumor formation and hyperproliferation in response to chemical carcinogens.

Area of Science:

  • Oncology
  • Dermatology
  • Molecular Biology

Background:

  • Altered expression of tetraspanin CD151 is linked to skin tumorigenesis.
  • The precise causal role of CD151 in tumor development remains unclear.

Purpose of the Study:

  • To investigate the functional role of CD151 in chemical skin carcinogenesis.
  • To determine if CD151 is essential for tumor formation and hyperproliferation in response to carcinogens.

Main Methods:

  • Utilized epidermis-specific Cd151 knockout mice for chemical skin carcinogenesis studies.
  • Administered 7,12-dimethylbenzanthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) to induce skin tumors.
  • Assessed tumor development, epidermal hyperproliferation, and epidermal turnover.
  • Investigated genetic interactions between CD151 and integrin alpha-3 (Itga3).

Main Results:

  • Mice lacking epidermal CD151 developed significantly fewer and smaller tumors after DMBA/TPA treatment compared to wild-type mice.
  • Cd151-null epidermis exhibited a reduced hyperproliferative response to TPA, with increased epidermal turnover.
  • Tumor formation was similar after DMBA-only treatment, suggesting CD151's role is TPA-dependent.
  • Genetic ablation of Itga3 also reduced skin tumor formation, and combined heterozygosity for Cd151 and Itga3 demonstrated a genetic interaction, with Itga3 heterozygosity diminishing tumorigenesis in Cd151-null mice.

Conclusions:

  • CD151 is identified as a critical factor in TPA-dependent skin carcinogenesis.
  • The absence of CD151 impairs the hyperproliferative response to TPA, leading to reduced tumor development.
  • A genetic interaction exists between CD151 and Itga3 in the context of skin tumor formation.

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular cells,...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...